MEDSCI (02415) released its annual performance, with a net profit attributable to shareholders of 1793.7 million yuan, a decrease of 28.16% compared to the previous year.

date
00:05 01/04/2026
avatar
GMT Eight
Meds Health (02415) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 270 million RMB during the period, an increase of 3.74% year-on-year. The attributable profit to the owners of the parent company was 17.937 million RMB, a decrease of 28.16% year-on-year. Earnings per share were 0.03 RMB.
MEDSCI (02415) announced the annual performance for the year ending on December 31, 2025. The group achieved revenue of 270 million yuan during the period, a year-on-year increase of 3.74%. The attributable profit to the owners of the parent company was 17.937 million yuan, a year-on-year decrease of 28.16%. The basic earnings per share were 0.03 yuan.